StapleBio

Operator of a nucleic acid-based therapeutic platform intended to modulate target protein expression levels for treating cancer, CNS disorders, autoimmune diseases, viral infections, and rare heredita...

Healthcare

Kumamoto, Japan

Founded 2021

Website

Valuation

$10.8M

Market implied

Share Price

N/A

Total Raised

$4.2M

Last Round

N/A

Investors

+6 other investors

View all 6 investors

Valuation History

0 funding rounds on record

Cap Table

Ownership structure

Market Activity

Secondary transactions

Get the full picture

Create a free account to unlock StapleBio's funding history, team members, investor details, and more.

15 free profiles/month · No credit card required